CCCC C4 Therapeutics 8-K2021C4 Therapeutics Announces Key 2021 Milestones to Support Progress Toward Goal of Four Clinical-Stage Programs by Year-End 2022
6 Jan 21
Files
SEC
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
CCCC 8-K Filings
- 12 Jan 21 Results of Operations and Financial Condition
- 6 Jan 21 C4 Therapeutics Announces Key 2021 Milestones to Support Progress Toward Goal of Four Clinical-Stage Programs by Year-End 2022
- 19 Nov 20 Regulation FD Disclosure
- 12 Nov 20 C4 Therapeutics Reports Business Highlights and Third Quarter
- 6 Oct 20 Departure of Directors or Certain Officers
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…